ArticleJournal of advanced research2023

GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma.

Wenliang Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.